Ristoff Kime J is categorized under Internal Medicine Practitioners in Camillus, NY and active since 2010.
Ristoff Kime J was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Kime Ristoff at the company’s single location by writing to 5700 West Genesee St, Camillus, New York NY 13031 or by phoning (315) 487-1573. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ristoff Kime J |
| Contact Person: | Kime Ristoff |
| Address: | 5700 West Genesee St, Camillus, New York 13031 |
| Phone Number: | (315) 487-1573 |
| Website Address: | fcmg.org |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Ristoff Kime J was started in 2010 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Kime Ristoff for inquiries that concern Ristoff Kime J by calling the company number (315) 487-1573, as your correspondence is most welcome. Additionally, the physical location of the single location of Ristoff Kime J can be found at the coordinates 43.03988,-76.29405 as well as the street address 5700 West Genesee St in Camillus, New York 13031.
For its online presence, you may visit Ristoff Kime J’s website at fcmg.org and engage with its social media outlets through on Twitter and on Facebook.